3 US Stocks That Might Be Estimated Under Their Intrinsic Value
As the United States stock market continues its upward trajectory, with the S&P 500 reaching a record closing high amid strong corporate earnings and optimism surrounding AI-related business ...
BioPharma Dive19h
Ascentage prices first biotech IPO of 2025, raising $126M
The China-based cancer drug developer’s offering will fund testing of medicines for several blood malignancies — one of which is part of an alliance with Takeda.
Discover 3 US Stocks Including Microchip Technology That May Be Trading Below Estimated Fair Value
As the U.S. stock market approaches record highs, driven by a surge in AI-related stocks and strong earnings reports, investors are keenly searching for opportunities that might be trading below their ...
阿思達克財經網2d
BEIGENE (06160.HK) Climbs 6% in Early Session, Expects to Achieve Positive Operating Income This Yr
BEIGENE (06160.HK) announced that according to US GAAP, the company expects to achieve positive operating income for the full ...
BeiGene (NASDAQ:BGNE) Earns Hold Rating from Analysts at StockNews.com
StockNews.com initiated coverage on shares of BeiGene (NASDAQ:BGNE – Free Report) in a research note issued to investors on Sunday. The brokerage issued a hold rating on the stock. Several other ...